FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

765509006: Product containing precisely carbidopa (as carbidopa monohydrate) 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug)


    Status: retired, Primitive. Date: 31-Jul 2021. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    3674197013 Product containing precisely carbidopa (as carbidopa monohydrate) 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug) en Fully specified name Active Case insensitive SNOMED CT core
    3674199011 Carbidopa (as carbidopa monohydrate) 50 mg and levodopa 200 mg prolonged-release oral tablet en Synonym Active Case insensitive SNOMED CT core


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Carbidopa (as carbidopa monohydrate) 50 mg and levodopa 200 mg prolonged-release oral tablet Is a Carbidopa and levodopa only product in oral dose form false Inferred relationship Some
    Carbidopa (as carbidopa monohydrate) 50 mg and levodopa 200 mg prolonged-release oral tablet Plays role Antiparkinson therapeutic role false Inferred relationship Some
    Carbidopa (as carbidopa monohydrate) 50 mg and levodopa 200 mg prolonged-release oral tablet Has manufactured dose form Extended-release oral tablet false Inferred relationship Some
    Carbidopa (as carbidopa monohydrate) 50 mg and levodopa 200 mg prolonged-release oral tablet Is a Carbidopa- and levodopa-containing product in oral dose form false Inferred relationship Some
    Carbidopa (as carbidopa monohydrate) 50 mg and levodopa 200 mg prolonged-release oral tablet Has presentation strength denominator value 1 false Inferred relationship Some 2
    Carbidopa (as carbidopa monohydrate) 50 mg and levodopa 200 mg prolonged-release oral tablet Has presentation strength numerator value 50 false Inferred relationship Some 1
    Carbidopa (as carbidopa monohydrate) 50 mg and levodopa 200 mg prolonged-release oral tablet Has presentation strength denominator value 1 false Inferred relationship Some 1
    Carbidopa (as carbidopa monohydrate) 50 mg and levodopa 200 mg prolonged-release oral tablet Has presentation strength denominator unit Tablet false Inferred relationship Some 2
    Carbidopa (as carbidopa monohydrate) 50 mg and levodopa 200 mg prolonged-release oral tablet Has precise active ingredient Carbidopa monohydrate false Inferred relationship Some 1
    Carbidopa (as carbidopa monohydrate) 50 mg and levodopa 200 mg prolonged-release oral tablet Has BoSS Levodopa false Inferred relationship Some 2
    Carbidopa (as carbidopa monohydrate) 50 mg and levodopa 200 mg prolonged-release oral tablet Has presentation strength numerator unit mg false Inferred relationship Some 2
    Carbidopa (as carbidopa monohydrate) 50 mg and levodopa 200 mg prolonged-release oral tablet Has presentation strength numerator value 200 false Inferred relationship Some 2
    Carbidopa (as carbidopa monohydrate) 50 mg and levodopa 200 mg prolonged-release oral tablet Has precise active ingredient Levodopa false Inferred relationship Some 2
    Carbidopa (as carbidopa monohydrate) 50 mg and levodopa 200 mg prolonged-release oral tablet Has unit of presentation Tablet false Inferred relationship Some
    Carbidopa (as carbidopa monohydrate) 50 mg and levodopa 200 mg prolonged-release oral tablet Has presentation strength numerator unit mg false Inferred relationship Some 1
    Carbidopa (as carbidopa monohydrate) 50 mg and levodopa 200 mg prolonged-release oral tablet Has BoSS Carbidopa false Inferred relationship Some 1
    Carbidopa (as carbidopa monohydrate) 50 mg and levodopa 200 mg prolonged-release oral tablet Has presentation strength denominator unit Tablet false Inferred relationship Some 1
    Carbidopa (as carbidopa monohydrate) 50 mg and levodopa 200 mg prolonged-release oral tablet Count of base of active ingredient 2 false Inferred relationship Some

    Inbound Relationships Type Active Source Characteristic Refinability Group

    Reference Sets

    Concept inactivation indicator reference set

    REPLACED BY association reference set

    Back to Start